INTERNATIONAL PATENT: HANGZHOU MATRIX BIOPHARMACEUTICAL CO., LTD., 杭州矩阵生物药业有限公司 FILES APPLICATION FOR "SULFONYLUREA DERIVATIVE HAVING NLRP3 INHIBITORY ACTIVITY AND USE THEREOF"

GENEVA, Aug. 17 -- HANGZHOU MATRIX BIOPHARMACEUTICAL CO., LTD. (Room F213, Building 1, 1378 Wenyi West Road, Cangqian Sub-District, Yuhang DistrictHangzhou, Zhejiang 311121), 杭州矩阵生物药业有限公司 (中国浙江省杭州市余杭区仓前街道文一西路1378号1幢F213室) filed a patent application (PCT/CN2025/076517) for "SULFONYLUREA DERIVATIVE HAVING NLRP3 INHIBITORY ACTIVITY AND USE THEREOF" on Feb 08, 2025. With publication no. WO/2025/168118, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application ...